MongoDB, Inc. (NASDAQ: MDB) Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/06/2023 | 21.6% | Piper Sandler | $425 → $500 | Maintains | Overweight |
| 12/04/2023 | 9.44% | Stifel | → $450 | Reiterates | Buy → Buy |
| 11/16/2023 | 21.6% | Wells Fargo | → $500 | Initiates Coverage On | → Overweight |
| 11/13/2023 | 4.57% | Truist Securities | → $430 | Reiterates | Buy → Buy |
| 11/08/2023 | 3.84% | Capital One | → $427 | Upgrades | Equal-Weight → Overweight |
| 10/23/2023 | 7% | Keybanc | $495 → $440 | Maintains | Overweight |
| 10/12/2023 | 9.44% | B of A Securities | → $450 | Initiates Coverage On | → Buy |
| 10/10/2023 | -18.53% | Scotiabank | → $335 | Initiates Coverage On | → Sector Perform |
| 10/06/2023 | 20.38% | Tigress Financial | $490 → $495 | Reiterates | Buy → Buy |
| 09/05/2023 | 9.44% | Canaccord Genuity | $410 → $450 | Maintains | Buy |
| 09/05/2023 | 17.7% | Argus Research | $435 → $484 | Maintains | Buy |
| 09/01/2023 | 13.08% | UBS | $425 → $465 | Maintains | Buy |
| 09/01/2023 | 4.57% | Truist Securities | $420 → $430 | Maintains | Buy |
| 09/01/2023 | 16.73% | Morgan Stanley | $440 → $480 | Maintains | Overweight |
| 09/01/2023 | 8.22% | RBC Capital | → $445 | Reiterates | Outperform → Outperform |
| 09/01/2023 | 9.44% | Barclays | $421 → $450 | Maintains | Overweight |
| 09/01/2023 | -39.2% | Guggenheim | $220 → $250 | Maintains | Sell |
| 09/01/2023 | 9.44% | Stifel | $420 → $450 | Maintains | Buy |
| 09/01/2023 | 16.73% | Oppenheimer | $430 → $480 | Maintains | Outperform |
| 09/01/2023 | 7% | JMP Securities | $425 → $440 | Maintains | Market Outperform |
| 09/01/2023 | 8.22% | Needham | $430 → $445 | Maintains | Buy |
| 09/01/2023 | 3.36% | Piper Sandler | $400 → $425 | Maintains | Overweight |
| 08/28/2023 | 10.65% | Citigroup | $430 → $455 | Maintains | Buy |
| 07/24/2023 | 3.36% | JMP Securities | $400 → $425 | Maintains | Outperform |
| 07/21/2023 | 12.35% | Keybanc | $372 → $462 | Maintains | Overweight |
| 06/28/2023 | 19.16% | Tigress Financial | $365 → $490 | Maintains | Buy |
| 06/26/2023 | 2.38% | Barclays | $374 → $421 | Maintains | Overweight |
| 06/26/2023 | -3.7% | Capital One | → $396 | Initiates Coverage On | → Equal-Weight |
| 06/23/2023 | 2.14% | Truist Securities | $365 → $420 | Maintains | Buy |
| 06/23/2023 | 7% | Morgan Stanley | $270 → $440 | Maintains | Overweight |
| 06/23/2023 | 8.22% | RBC Capital | $400 → $445 | Maintains | Outperform |
| 06/23/2023 | -0.29% | Wedbush | → $410 | Reiterates | Outperform → Outperform |
| 06/23/2023 | 4.57% | Needham | → $430 | Reiterates | Buy → Buy |
| 06/23/2023 | -2.72% | Piper Sandler | → $400 | Reiterates | Overweight → Overweight |
| 06/06/2023 | -0.29% | Canaccord Genuity | $250 → $410 | Maintains | Buy |
| 06/05/2023 | 2.14% | Goldman Sachs | $280 → $420 | Maintains | Buy |
| 06/05/2023 | 3.11% | Bernstein | $257 → $424 | Maintains | Outperform |
| 06/02/2023 | -2.72% | RBC Capital | $235 → $400 | Maintains | Outperform |
| 06/02/2023 | -8.8% | Stifel | $240 → $375 | Maintains | Buy |
| 06/02/2023 | -11.24% | Truist Securities | $235 → $365 | Maintains | Buy |
| 06/02/2023 | -46.5% | Mizuho | $180 → $220 | Maintains | Neutral |
| 06/02/2023 | 4.57% | Oppenheimer | $270 → $430 | Maintains | Outperform |
| 06/02/2023 | 4.57% | Needham | $250 → $430 | Maintains | Buy |
| 06/02/2023 | -5.16% | Baird | $290 → $390 | Maintains | Outperform |
| 06/02/2023 | 4.57% | Citigroup | $363 → $430 | Maintains | Buy |
| 06/02/2023 | -9.05% | Barclays | $280 → $374 | Maintains | Overweight |
| 06/02/2023 | -10.02% | JMP Securities | $245 → $370 | Maintains | Market Outperform |
| 06/02/2023 | 2.14% | Goldman Sachs | $280 → $420 | Maintains | Buy |
| 06/02/2023 | -2.72% | Piper Sandler | $270 → $400 | Maintains | Overweight |
| 05/31/2023 | -29.47% | Baird | $230 → $290 | Maintains | Outperform |
| 05/26/2023 | -48.93% | Guggenheim | $205 → $210 | Downgrades | Neutral → Sell |
| 05/19/2023 | -11.72% | Citigroup | $290 → $363 | Maintains | Buy |
| 05/15/2023 | -31.91% | Barclays | $257 → $280 | Maintains | Overweight |
| 04/20/2023 | -11.24% | Tigress Financial | → $365 | Reiterates | → Buy |
| 04/20/2023 | -35.8% | Keybanc | $229 → $264 | Maintains | Overweight |
| 04/12/2023 | -34.34% | Morgan Stanley | $230 → $270 | Upgrades | Equal-Weight → Overweight |
| 03/10/2023 | -39.2% | Credit Suisse | $305 → $250 | Maintains | Outperform |
| 03/09/2023 | -44.07% | Baird | → $230 | Maintains | Outperform |
| 03/09/2023 | -42.85% | RBC Capital | → $235 | Reiterates | → Outperform |
| 03/09/2023 | -31.91% | Goldman Sachs | $325 → $280 | Maintains | Buy |
| 03/09/2023 | -39.2% | Needham | $240 → $250 | Maintains | Buy |
| 03/09/2023 | -56.23% | Mizuho | $220 → $180 | Maintains | Neutral |
| 03/09/2023 | -29.47% | Citigroup | $295 → $290 | Maintains | Buy |
| 03/09/2023 | -34.34% | Oppenheimer | $320 → $270 | Maintains | Outperform |
| 03/09/2023 | -40.42% | JMP Securities | $215 → $245 | Maintains | Market Outperform |
| 03/09/2023 | -37.5% | Barclays | $264 → $257 | Maintains | Overweight |
| 03/09/2023 | -34.34% | Piper Sandler | → $270 | Reiterates | → Overweight |
| 03/07/2023 | -28.26% | Citigroup | $300 → $295 | Maintains | Buy |
| 02/22/2023 | -41.63% | Stifel | $256 → $240 | Maintains | Buy |
| 02/17/2023 | -31.42% | Bernstein | → $282 | Initiates Coverage On | → Outperform |
| 02/15/2023 | -35.8% | Barclays | $240 → $264 | Maintains | Overweight |
| 02/15/2023 | -46.5% | Mizuho | $170 → $220 | Maintains | Neutral |
| 02/06/2023 | -37.99% | Keybanc | $220 → $255 | Maintains | Overweight |
| 01/27/2023 | -50.15% | Guggenheim | → $205 | Initiates Coverage On | → Neutral |
| 01/08/2023 | -42.85% | Truist Securities | $300 → $235 | Maintains | Buy |
| 12/21/2022 | -41.63% | Needham | $225 → $240 | Maintains | Buy |
| 12/15/2022 | -11.24% | Tigress Financial | $575 → $365 | Maintains | Buy |
| 12/15/2022 | -41.63% | Wedbush | → $240 | Initiates Coverage On | → Outperform |
| 12/07/2022 | -37.74% | Stifel | $320 → $256 | Maintains | Buy |
| 12/07/2022 | -22.18% | Oppenheimer | $375 → $320 | Maintains | Outperform |
| 12/07/2022 | -44.07% | Morgan Stanley | $215 → $230 | Maintains | Equal-Weight |
| 12/07/2022 | -20.96% | Goldman Sachs | $380 → $325 | Maintains | Buy |
| 12/07/2022 | -41.63% | Barclays | $233 → $240 | Maintains | Overweight |
| 12/07/2022 | -25.83% | Credit Suisse | $400 → $305 | Maintains | Outperform |
| 12/07/2022 | -58.66% | Mizuho | $190 → $170 | Maintains | Neutral |
| 12/07/2022 | -47.71% | UBS | $200 → $215 | Maintains | Buy |
| 12/07/2022 | -47.71% | JMP Securities | → $215 | Upgrades | Market Perform → Market Outperform |
| 12/07/2022 | -45.28% | Needham | $330 → $225 | Maintains | Buy |
| 12/05/2022 | -50.15% | Baird | $330 → $205 | Maintains | Outperform |
| 11/29/2022 | -51.36% | UBS | $390 → $200 | Maintains | Buy |
| 11/28/2022 | -28.26% | Citigroup | $445 → $295 | Maintains | Buy |
| 11/21/2022 | -47.71% | Keybanc | → $215 | Initiates Coverage On | → Overweight |
| 11/21/2022 | -47.71% | Morgan Stanley | $368 → $215 | Downgrades | Overweight → Equal-Weight |
| 11/18/2022 | -43.34% | Barclays | $300 → $233 | Maintains | Overweight |
| 11/15/2022 | -53.79% | Mizuho | $300 → $190 | Maintains | Neutral |
| 10/20/2022 | -34.34% | Piper Sandler | $350 → $270 | Maintains | Overweight |
| 10/18/2022 | — | Redburn Partners | Upgrades | Sell → Neutral | |
| 10/18/2022 | -27.04% | Barclays | $360 → $300 | Maintains | Overweight |
| 09/30/2022 | -27.04% | Truist Securities | → $300 | Initiates Coverage On | → Buy |
| 09/01/2022 | -22.18% | Stifel | $340 → $320 | Maintains | Buy |
| 09/01/2022 | -12.45% | Canaccord Genuity | $300 → $360 | Maintains | Buy |
| 09/01/2022 | -19.75% | Baird | $360 → $330 | Maintains | Outperform |
| 09/01/2022 | -5.16% | UBS | $430 → $390 | Maintains | Buy |
| 09/01/2022 | -2.72% | Credit Suisse | $500 → $400 | Maintains | Outperform |
| 09/01/2022 | -19.75% | Needham | $350 → $330 | Maintains | Buy |
| 09/01/2022 | -14.88% | RBC Capital | $400 → $350 | Maintains | Outperform |
| 09/01/2022 | 8.22% | Citigroup | $450 → $445 | Maintains | Buy |
| 09/01/2022 | -12.45% | Barclays | $438 → $360 | Maintains | Overweight |
| 09/01/2022 | -14.88% | Piper Sandler | $375 → $350 | Maintains | Overweight |
| 08/22/2022 | 9.44% | Citigroup | $425 → $450 | Maintains | Buy |
| 08/17/2022 | -5.16% | Mizuho | $270 → $390 | Maintains | Buy |
| 08/16/2022 | 6.52% | Barclays | $338 → $438 | Maintains | Overweight |
| 07/18/2022 | -8.8% | Piper Sandler | $430 → $375 | Maintains | Overweight |
| 07/13/2022 | -12.45% | Baird | → $360 | Initiates Coverage On | → Outperform |
| 06/29/2022 | -53.79% | Redburn Partners | → $190 | Initiates Coverage On | → Sell |
| 06/10/2022 | -14.88% | Needham | $310 → $350 | Maintains | Buy |
| 06/09/2022 | -8.8% | RBC Capital | $325 → $375 | Maintains | Outperform |
| 06/08/2022 | -16.1% | UBS | $315 → $345 | Maintains | Buy |
| 06/02/2022 | 3.36% | Citigroup | $405 → $425 | Maintains | Buy |
| 06/02/2022 | -17.32% | Stifel | $425 → $340 | Maintains | Buy |
| 06/02/2022 | -27.04% | Canaccord Genuity | $400 → $300 | Maintains | Buy |
| 06/02/2022 | -10.51% | Morgan Stanley | $378 → $368 | Maintains | Overweight |
| 06/02/2022 | 21.6% | Credit Suisse | $650 → $500 | Maintains | Outperform |
| 06/02/2022 | -2.72% | Oppenheimer | $490 → $400 | Maintains | Outperform |
| 06/02/2022 | -17.8% | Barclays | $330 → $338 | Maintains | Overweight |
| 06/02/2022 | -24.61% | Needham | $362 → $310 | Maintains | Buy |
| 06/02/2022 | 4.57% | Piper Sandler | $585 → $430 | Maintains | Overweight |
| 06/01/2022 | -1.51% | Citigroup | $525 → $405 | Maintains | Buy |
| 05/20/2022 | -19.75% | Barclays | $410 → $330 | Maintains | Overweight |
| 05/19/2022 | -8.07% | Morgan Stanley | $475 → $378 | Maintains | Overweight |
| 05/18/2022 | -34.34% | Mizuho | $325 → $270 | Maintains | Neutral |
| 03/18/2022 | 9.44% | UBS | $345 → $450 | Upgrades | Neutral → Buy |
| 03/16/2022 | 15.52% | Morgan Stanley | $633 → $475 | Maintains | Overweight |
| 03/09/2022 | 3.36% | Stifel | $550 → $425 | Maintains | Buy |
| 03/09/2022 | -11.96% | Needham | $626 → $362 | Maintains | Buy |
| 03/09/2022 | -20.96% | Mizuho | $400 → $325 | Maintains | Neutral |
| 03/09/2022 | -0.29% | Barclays | $556 → $410 | Maintains | Overweight |
| 03/09/2022 | 58.07% | Credit Suisse | $700 → $650 | Maintains | Outperform |
| 03/01/2022 | 22.81% | RBC Capital | → $505 | Initiates Coverage On | → Outperform |
| 02/15/2022 | -2.72% | Mizuho | $490 → $400 | Maintains | Neutral |
| 02/11/2022 | 53.21% | Tigress Financial | → $630 | Initiates Coverage On | → Buy |
| 12/16/2021 | 53.94% | Morgan Stanley | $525 → $633 | Maintains | Overweight |
| 12/08/2021 | 32.54% | Goldman Sachs | $475 → $545 | Maintains | Buy |
| 12/07/2021 | 33.75% | Stifel | $495 → $550 | Maintains | Buy |
| 12/07/2021 | 36.19% | Canaccord Genuity | $475 → $560 | Maintains | Buy |
| 12/07/2021 | 27.68% | Morgan Stanley | $480 → $525 | Maintains | Overweight |
| 12/07/2021 | 60.51% | Citigroup | $526 → $660 | Maintains | Buy |
| 12/07/2021 | 19.16% | Mizuho | $475 → $490 | Maintains | Neutral |
| 12/07/2021 | 52.24% | Needham | $534 → $626 | Maintains | Buy |
| 12/07/2021 | 42.27% | Piper Sandler | $525 → $585 | Maintains | Overweight |
| 11/16/2021 | 70.23% | Credit Suisse | → $700 | Initiates Coverage On | → Outperform |
| 09/17/2021 | 43.48% | Barclays | $505 → $590 | Maintains | Overweight |
| 09/07/2021 | 33.75% | Argus Research | $406 → $550 | Maintains | Buy |
| 09/03/2021 | 20.38% | Stifel | $384 → $495 | Maintains | Buy |
| 09/03/2021 | 9.44% | UBS | $300 → $450 | Maintains | Neutral |
| 09/03/2021 | 16.73% | Morgan Stanley | $410 → $480 | Maintains | Overweight |
| 09/03/2021 | 14.3% | Oppenheimer | $400 → $470 | Maintains | Outperform |
| 09/03/2021 | 29.86% | Needham | $415 → $534 | Maintains | Buy |
| 09/03/2021 | -0.29% | Mizuho | $350 → $410 | Maintains | Neutral |
| 09/03/2021 | 22.81% | Barclays | $420 → $505 | Maintains | Overweight |
| 09/03/2021 | 27.68% | Piper Sandler | $425 → $525 | Maintains | Overweight |
| 08/24/2021 | -0.29% | Morgan Stanley | $377 → $410 | Maintains | Overweight |
| 08/23/2021 | 2.14% | Barclays | $390 → $420 | Maintains | Overweight |
| 07/14/2021 | -3.94% | Canaccord Genuity | $375 → $395 | Maintains | Buy |
| 07/14/2021 | -22.18% | Mizuho | $300 → $320 | Maintains | Neutral |
| 06/04/2021 | 9.44% | Citigroup | $445 → $450 | Maintains | Buy |
| 06/04/2021 | -27.04% | UBS | $325 → $300 | Maintains | Neutral |
| 06/04/2021 | -27.04% | Mizuho | $265 → $300 | Maintains | Neutral |
| 06/04/2021 | 0.92% | Needham | $409 → $415 | Maintains | Buy |
| 05/25/2021 | -8.32% | Morgan Stanley | $415 → $377 | Maintains | Overweight |
| 05/14/2021 | -24.61% | Goldman Sachs | → $310 | Initiates Coverage On | → Buy |
| 04/13/2021 | -22.18% | Mizuho | → $320 | Initiates Coverage On | → Neutral |
| 03/23/2021 | -20.96% | UBS | → $325 | Initiates Coverage On | → Neutral |
| 03/12/2021 | -1.26% | Argus Research | → $406 | Upgrades | Hold → Buy |
| 03/10/2021 | -27.04% | DA Davidson | $275 → $300 | Maintains | Neutral |
| 03/10/2021 | 0.92% | Morgan Stanley | $439 → $415 | Maintains | Overweight |
| 03/10/2021 | -8.8% | Canaccord Genuity | $430 → $375 | Maintains | Buy |
| 03/10/2021 | -0.54% | Needham | $394 → $409 | Maintains | Buy |
| 02/23/2021 | 21.6% | Citigroup | $465 → $500 | Maintains | Buy |
| 01/19/2021 | -4.18% | Needham | $341 → $394 | Maintains | Buy |
| 12/21/2020 | -6.61% | Stifel | $320 → $384 | Maintains | Buy |
| 12/17/2020 | 6.76% | Morgan Stanley | $295 → $439 | Upgrades | Equal-Weight → Overweight |
| 12/09/2020 | -23.39% | Canaccord Genuity | $290 → $315 | Maintains | Buy |
| 12/09/2020 | -17.07% | Needham | $290 → $341 | Maintains | Buy |
| 12/09/2020 | -20.23% | Piper Sandler | $310 → $328 | Maintains | Overweight |
| 12/07/2020 | -28.26% | Morgan Stanley | $270 → $295 | Maintains | Equal-Weight |
| 09/03/2020 | -30.2% | Barclays | $280 → $287 | Maintains | Overweight |
| 09/03/2020 | -22.18% | Stifel | $225 → $320 | Maintains | Buy |
| 09/03/2020 | -40.42% | Goldman Sachs | $215 → $245 | Maintains | Neutral |
| 09/03/2020 | -29.47% | Canaccord Genuity | $245 → $290 | Maintains | Buy |
| 09/03/2020 | -34.34% | Morgan Stanley | $205 → $270 | Maintains | Equal-Weight |
| 09/03/2020 | -33.12% | Oppenheimer | $240 → $275 | Maintains | Outperform |
| 09/03/2020 | -29.47% | Needham | $259 → $290 | Maintains | Buy |
| 09/03/2020 | -24.61% | Piper Sandler | $226 → $310 | Maintains | Overweight |
| 06/11/2020 | -50.15% | Morgan Stanley | $203 → $205 | Maintains | Equal-Weight |
| 06/05/2020 | -45.04% | Piper Sandler | $138 → $226 | Maintains | Overweight |
| 06/05/2020 | -37.01% | Needham | $253 → $259 | Maintains | Buy |
| 06/02/2020 | -38.47% | Needham | $170 → $253 | Maintains | Buy |
| 06/01/2020 | -50.63% | Morgan Stanley | $141 → $203 | Maintains | Equal-Weight |
| 05/28/2020 | -33.12% | Citigroup | $175 → $275 | Maintains | Buy |
| 05/22/2020 | -45.28% | Stifel | $160 → $225 | Maintains | Buy |
| 04/27/2020 | -58.66% | Needham | $172 → $170 | Maintains | Buy |
| 04/20/2020 | -61.09% | Stifel | $135 → $160 | Maintains | Buy |
| 03/18/2020 | -58.17% | Needham | $189 → $172 | Maintains | Buy |
| 03/18/2020 | -67.17% | Stifel | $185 → $135 | Maintains | Buy |
| 03/18/2020 | -57.44% | Citigroup | $200 → $175 | Maintains | Buy |
| 01/13/2020 | -58.41% | Morgan Stanley | $160 → $171 | Maintains | Equal-Weight |
| 01/06/2020 | — | Argus Research | Initiates Coverage On | → Hold | |
| 12/10/2019 | -59.87% | Canaccord Genuity | $185 → $165 | Maintains | Buy |
| 12/10/2019 | -61.09% | Morgan Stanley | $150 → $160 | Maintains | Equal-Weight |
| 12/10/2019 | -81.03% | Nomura | $76 → $78 | Maintains | Reduce |
| 10/29/2019 | -61.58% | Piper Sandler | → $158 | Initiates Coverage On | → Overweight |
| 10/16/2019 | -63.52% | Morgan Stanley | $160 → $150 | Maintains | Equal-Weight |
| 10/11/2019 | -62.31% | Oppenheimer | $180 → $155 | Maintains | Outperform |
| 09/05/2019 | -61.09% | Morgan Stanley | $156 → $160 | Maintains | Equal-Weight |
| 09/05/2019 | -55.01% | Stifel | $180 → $185 | Maintains | Buy |
| 09/05/2019 | -52.58% | Citigroup | $184 → $195 | Maintains | Buy |
| 09/05/2019 | -52.58% | Citigroup | $184 → $195 | Maintains | Buy |
| 09/05/2019 | -56.47% | Barclays | $178 → $179 | Maintains | Overweight |
| 08/27/2019 | -55.25% | Citigroup | $162 → $184 | Upgrades | Neutral → Buy |
| 08/13/2019 | -62.31% | Compass Point | → $155 | Initiates Coverage On | → Neutral |
| 06/19/2019 | -55.01% | Canaccord Genuity | $160 → $185 | Maintains | Buy |
| 06/19/2019 | -56.23% | Stifel | $155 → $180 | Maintains | Buy |
| 06/19/2019 | -54.28% | Keybanc | $165 → $188 | Maintains | Overweight |
| 06/06/2019 | -61.09% | Canaccord Genuity | $125 → $160 | Maintains | Buy |
| 06/06/2019 | -81.52% | Nomura | $70 → $76 | Maintains | Reduce |
| 06/06/2019 | -59.87% | Keybanc | $150 → $165 | Maintains | Overweight |
| 05/23/2019 | -62.79% | Morgan Stanley | $124 → $153 | Maintains | Equal-Weight |
| 05/15/2019 | -56.71% | Barclays | $143 → $178 | Maintains | Overweight |
| 03/14/2019 | -71.79% | Citigroup | $94 → $116 | Maintains | Neutral |
| 03/14/2019 | -69.6% | Canaccord Genuity | $95 → $125 | Maintains | Buy |
| 03/14/2019 | -63.52% | Keybanc | $100 → $150 | Maintains | Overweight |
| 12/06/2018 | -77.14% | Citigroup | $86 → $94 | Maintains | Neutral |